Latest Market News

Bass Oil’s September-quarter production rose 21% to 23,944 barrels after Bunian 6 came online, while sales revenue reached A$2.82 million. Cash fell to A$2.07 million as drilling and development spending continued, leaving the company with an estimated two quarters of funding under its Appendix 5B calculation.

Identitii has lodged a prospectus for up to 4.435 million free options, designed to give shareholders a way to partly offset dilution from its convertible note funding. The offer costs nothing upfront, but the options are unquoted, time-limited and sit alongside a funding package that still has $2.4 million to be received.

Australian Silica Quartz Group has completed a 200-tonne bulk sample at White Swan and is preparing 50 tonnes for shipment to prospective Chinese customers. The customer program is advancing, but ASQ held $912,000 in cash at quarter-end and estimated only 1.7 quarters of funding without proceeds from a Bindoon property sale.

Challenger Gold has completed the first US$15 million tranche of its convertible debenture raise, giving the Hualilan development a near-term funding base. A further US$15.3 million is agreed in principle, but part of it remains subject to shareholder and potentially ASX approval.

European Metals has given in-principle approval to replace Cinovec’s two gas-fired rotary kilns with a single kiln that can run on gas or electricity. Testwork indicates comparable or improved lithium recovery at lower temperatures, with expected reductions in processing-plant capital and operating costs.

dorsaVi has commercially launched its first wearable capable of analysing movement and delivering feedback directly on-device, while its RRAM chip program moves into fabrication and testing. The progress comes alongside a post-quarter A$3.0 million capital raising, against quarter-end cash of $1.12 million and operating cash outflow of about $996,000.

Carnegie Clean Energy has moved its flagship CETO wave-energy project towards offshore deployment in Spain, but the technology developer ended 2026 with a wider loss, $996,347 in cash and a material uncertainty over its ability to continue as a going concern.

Beamtree Holdings has paired 10% recurring revenue growth with a $13.1 million non-cash impairment and a year-end debt covenant breach. The ASX-listed healthcare software company is betting that a tighter product portfolio, new leadership and FY27 execution can stabilise the balance sheet.

Alara Resources has reported its first full-year profit after its Oman copper operation produced above nameplate capacity, lifting revenue 145% to A$135.3 million. The turnaround is substantial, but negative operating cash flow and a planned A$6 million equity raise keep the balance sheet firmly in focus.

New research from the NEPTUNE cohort has strengthened the biological rationale for Dimerix’s DMX-200 kidney drug, linking CCR2 activity and urinary MCP-1 levels with poorer outcomes in FSGS. The findings support the drug’s mechanism, but do not yet demonstrate Phase 3 efficacy.

Element 25 has moved its Butcherbird expansion further into delivery, combining early site works with a binding manganese offtake and a potential AU$50 million project finance package. The project still needs financial close, approvals and major construction contracts before the plan becomes an operating mine.

EVT delivered a 17% lift in normalised first-quarter EBITDA to $72.5 million, powered by a sharp recovery in Entertainment and resilient Hotels trading. Thredbo was the drag, while an $800 million property sell-down and ongoing structure review put the group’s Hotels-led strategy under the spotlight.